News
But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...
One of four men arrested in connection to a drug bust at a Northwest Omaha convenience store last year changed his plea ...
Injectable medications originally developed for the treatment of diabetes are also effective for weight loss, and have surged ...
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...
A meta-analysis of studies examining the antidepressant effects of psychedelics has found that the strength of these effects ...
University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...
Guests include FIU's so-called "Psychedelic Professor" and Dr. Angela Fisher, who will administer psychedelic toad venom to a ...
It’s time to close the gap between patient interest in psychedelic therapies and clinical education, researchers say.
Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.
Research highlights the potential for modifying the chemical structures of psychedelics to produce analogues with improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results